Market Cap ₹17584 Cr.
Stock P/E 21.6
P/B 4.4
Current Price ₹3382
Book Value ₹ 764.3
Face Value 2
52W High ₹3687.7
Dividend Yield 1.3%
52W Low ₹ 1605.1
Godfrey Phillips India Ltd is an India-based business enterprise, which is engaged in production of cigarettes, tobacco merchandise and chewing merchandise and in trading of tobacco merchandise and different retail merchandise. Its segments comprises Cigarette, tobacco and associated merchandise; and Retail and associated merchandise. It offers cigarette under diverse brands, including Marlboro, Four Square, Red & White, Cavanders, Stellar and North Pole and Tipper. It offers chewing merchandise below numerous manufacturers , inclusive of Pan Vilas, Pan Vilas Silver Dewz and Raag. Its retail brand 24SEVEN, which is a convenience store chain with approximately 100 shops throughout Delhi National Capital Territory (NCR) and Chandigarh. It offers confectionery products underneath Funda Goli emblem, which includes flavours, consisting of tangy orange to rasili lychee, kaccha aam, mast guava and green apple. It manufactures composite leaf blends and cut tobacco. It also gives Roll-your-own (RYO) cigarettes.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 773 | 867 | 853 | 982 | 1192 | 1112 | 974 | 1245 | 1375 | 1488 |
Other Income | 35 | 27 | 25 | 2 | 43 | 79 | 44 | 53 | 38 | 57 |
Total Income | 808 | 894 | 878 | 984 | 1235 | 1191 | 1018 | 1298 | 1413 | 1545 |
Total Expenditure | 625 | 692 | 689 | 781 | 951 | 902 | 822 | 993 | 1151 | 1260 |
Operating Profit | 182 | 202 | 188 | 203 | 284 | 288 | 196 | 306 | 262 | 285 |
Interest | 8 | 8 | 11 | 6 | 7 | 7 | 9 | 7 | 7 | 6 |
Depreciation | 36 | 37 | 37 | 38 | 39 | 39 | 37 | 37 | 36 | 36 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 139 | 157 | 140 | 159 | 238 | 243 | 149 | 262 | 219 | 243 |
Provision for Tax | 34 | 40 | 36 | 28 | 60 | 56 | 39 | 41 | 56 | 60 |
Profit After Tax | 105 | 117 | 104 | 131 | 178 | 187 | 111 | 221 | 163 | 183 |
Adjustments | 0 | 0 | -0 | 11 | 24 | 12 | 37 | 33 | 39 | 30 |
Profit After Adjustments | 105 | 117 | 104 | 142 | 202 | 199 | 147 | 254 | 202 | 212 |
Adjusted Earnings Per Share | 20.2 | 22.5 | 20 | 27.4 | 38.8 | 38.3 | 28.3 | 48.9 | 38.9 | 40.8 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 2098 | 2479 | 2587 | 2331 | 2403 | 2326 | 2497 | 2877 | 2525 | 2688 | 3562 | 5082 |
Other Income | 29 | 27 | 32 | 37 | 47 | 55 | 79 | 107 | 119 | 114 | 168 | 192 |
Total Income | 2127 | 2506 | 2619 | 2368 | 2450 | 2380 | 2576 | 2983 | 2644 | 2802 | 3731 | 5274 |
Total Expenditure | 1771 | 2091 | 2220 | 2007 | 2150 | 2067 | 2094 | 2285 | 1984 | 2054 | 2759 | 4226 |
Operating Profit | 356 | 414 | 398 | 360 | 300 | 313 | 482 | 698 | 660 | 747 | 972 | 1049 |
Interest | 27 | 29 | 19 | 10 | 4 | 2 | 1 | 30 | 31 | 34 | 29 | 29 |
Depreciation | 93 | 91 | 108 | 107 | 98 | 98 | 99 | 155 | 141 | 145 | 154 | 146 |
Exceptional Income / Expenses | 0 | -35 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 237 | 259 | 271 | 244 | 199 | 233 | 383 | 514 | 487 | 568 | 873 | 873 |
Provision for Tax | 67 | 84 | 89 | 74 | 62 | 74 | 123 | 129 | 111 | 130 | 182 | 196 |
Profit After Tax | 169 | 175 | 183 | 170 | 137 | 159 | 260 | 385 | 376 | 438 | 690 | 678 |
Adjustments | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 139 |
Profit After Adjustments | 170 | 176 | 183 | 170 | 137 | 159 | 260 | 385 | 377 | 438 | 690 | 815 |
Adjusted Earnings Per Share | 32.7 | 33.8 | 35.3 | 32.6 | 26.4 | 30.6 | 50.1 | 74 | 72.4 | 84.3 | 132.8 | 156.9 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 33% | 7% | 9% | 5% |
Operating Profit CAGR | 30% | 12% | 25% | 11% |
PAT CAGR | 58% | 21% | 34% | 15% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 98% | 58% | 27% | 18% |
ROE Average | 21% | 18% | 17% | 15% |
ROCE Average | 28% | 23% | 23% | 20% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 1057 | 1184 | 1313 | 1576 | 1660 | 1793 | 2039 | 2187 | 2582 | 2928 | 3548 |
Minority's Interest | 2 | 1 | 4 | 44 | 40 | 37 | 33 | 29 | 5 | 5 | 5 |
Borrowings | 166 | 97 | 31 | 27 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Other Non-Current Liabilities | 45 | 33 | 36 | 58 | 74 | 71 | 56 | 365 | 353 | 345 | 374 |
Total Current Liabilities | 546 | 617 | 672 | 454 | 433 | 563 | 738 | 713 | 791 | 822 | 1040 |
Total Liabilities | 1817 | 1932 | 2057 | 2159 | 2208 | 2465 | 2866 | 3295 | 3732 | 4102 | 4968 |
Fixed Assets | 741 | 707 | 675 | 695 | 695 | 641 | 686 | 1006 | 1025 | 947 | 897 |
Other Non-Current Assets | 192 | 349 | 401 | 448 | 498 | 855 | 1093 | 1233 | 1183 | 1506 | 2652 |
Total Current Assets | 883 | 876 | 981 | 1012 | 1012 | 969 | 1087 | 1057 | 1524 | 1649 | 1419 |
Total Assets | 1817 | 1932 | 2057 | 2159 | 2208 | 2465 | 2866 | 3295 | 3732 | 4102 | 4968 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 13 | 12 | 10 | 11 | 15 | 11 | 23 | 31 | 32 | 28 | 34 |
Cash Flow from Operating Activities | 191 | 296 | 63 | 319 | 245 | 516 | 362 | 375 | 310 | 479 | 736 |
Cash Flow from Investing Activities | -86 | -140 | -32 | -119 | -125 | -405 | -310 | -72 | -298 | -234 | -541 |
Cash Flow from Financing Activities | -106 | -158 | -31 | -197 | -125 | -99 | -43 | -303 | -16 | -238 | -206 |
Net Cash Inflow / Outflow | -1 | -2 | 1 | 3 | -4 | 12 | 9 | 0 | -4 | 6 | -11 |
Closing Cash & Cash Equivalent | 12 | 10 | 11 | 13 | 11 | 23 | 31 | 32 | 28 | 34 | 23 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 32.7 | 33.76 | 35.26 | 32.63 | 26.39 | 30.6 | 50.07 | 74.02 | 72.41 | 84.25 | 132.8 |
CEPS(Rs) | 50.39 | 51.13 | 55.91 | 53.17 | 45.14 | 49.52 | 69.01 | 103.86 | 99.58 | 112.17 | 162.34 |
DPS(Rs) | 8 | 8 | 8 | 8 | 8 | 8 | 10 | 24 | 24 | 28 | 44 |
Book NAV/Share(Rs) | 203.37 | 227.78 | 252.46 | 303.09 | 319.35 | 344.92 | 392.11 | 420.69 | 496.61 | 563.06 | 682.37 |
Core EBITDA Margin(%) | 8.97 | 9.24 | 8.23 | 7.58 | 5.74 | 8.63 | 14.89 | 18.75 | 18.16 | 19.5 | 18.74 |
EBIT Margin(%) | 7.24 | 6.87 | 6.52 | 5.95 | 4.6 | 7.84 | 14.19 | 17.23 | 17.38 | 18.54 | 21.03 |
Pre Tax Margin(%) | 6.5 | 6.17 | 6.09 | 5.71 | 4.51 | 7.78 | 14.15 | 16.28 | 16.35 | 17.49 | 20.35 |
PAT Margin (%) | 4.65 | 4.17 | 4.1 | 3.98 | 3.1 | 5.31 | 9.62 | 12.2 | 12.63 | 13.48 | 16.1 |
Cash Profit Margin (%) | 7.19 | 6.34 | 6.53 | 6.48 | 5.32 | 8.6 | 13.26 | 17.12 | 17.37 | 17.95 | 19.69 |
ROA(%) | 9.76 | 9.33 | 9.15 | 8.05 | 6.27 | 6.81 | 9.77 | 12.49 | 10.71 | 11.18 | 15.22 |
ROE(%) | 17 | 15.6 | 14.62 | 11.75 | 8.46 | 9.21 | 13.58 | 18.21 | 15.79 | 15.9 | 21.32 |
ROCE(%) | 20.08 | 20.68 | 19.27 | 15.41 | 11.78 | 13.21 | 19.68 | 25.41 | 21.33 | 21.44 | 27.56 |
Receivable days | 7.73 | 7.96 | 9.56 | 10.17 | 11.87 | 16.14 | 10.42 | 7.95 | 11.75 | 15.6 | 12.95 |
Inventory Days | 46.34 | 49.33 | 54.65 | 63.36 | 57.48 | 75.42 | 82.73 | 76.9 | 87.62 | 88.31 | 74.78 |
Payable days | 61.35 | 56.53 | 49.58 | 46.75 | 39.97 | 50.11 | 78.34 | 78.67 | 72.69 | 72.37 | 63.35 |
PER(x) | 16.78 | 18.95 | 12.04 | 36.42 | 42.93 | 26.83 | 23.16 | 12.73 | 12.6 | 11.99 | 13.7 |
Price/Book(x) | 2.7 | 2.81 | 1.68 | 3.92 | 3.55 | 2.38 | 2.96 | 2.24 | 1.84 | 1.79 | 2.67 |
Dividend Yield(%) | 1.46 | 1.25 | 1.88 | 0.67 | 0.71 | 0.97 | 0.86 | 2.55 | 2.63 | 2.77 | 2.42 |
EV/Net Sales(x) | 1.49 | 1.43 | 0.95 | 2.69 | 2.47 | 1.83 | 2.41 | 1.69 | 1.89 | 1.95 | 2.65 |
EV/Core EBITDA(x) | 8.79 | 8.54 | 6.17 | 17.42 | 19.75 | 13.59 | 12.5 | 6.96 | 7.23 | 7 | 9.73 |
Net Sales Growth(%) | 9.79 | 18.18 | 4.36 | -9.91 | 3.09 | -3.2 | 7.38 | 15.19 | -12.21 | 6.42 | 32.55 |
EBIT Growth(%) | -8.72 | 9.14 | 0.83 | -12.49 | -20.07 | 15.77 | 63.78 | 41.6 | -4.62 | 16.22 | 49.72 |
PAT Growth(%) | -6.41 | 3.16 | 4.41 | -7.04 | -19.16 | 16.2 | 63.89 | 47.84 | -2.04 | 16.35 | 57.63 |
EPS Growth(%) | -6.32 | 3.24 | 4.43 | -7.45 | -19.12 | 15.94 | 63.61 | 47.85 | -2.17 | 16.35 | 57.62 |
Debt/Equity(x) | 0.29 | 0.2 | 0.21 | 0.08 | 0.04 | 0.02 | 0.02 | 0.01 | 0.03 | 0.01 | 0.01 |
Current Ratio(x) | 1.62 | 1.42 | 1.46 | 2.23 | 2.34 | 1.72 | 1.47 | 1.48 | 1.93 | 2 | 1.37 |
Quick Ratio(x) | 0.62 | 0.46 | 0.35 | 0.6 | 0.83 | 0.69 | 0.61 | 0.52 | 0.99 | 1 | 0.47 |
Interest Cover(x) | 9.8 | 9.93 | 15.16 | 25.07 | 56.88 | 140.63 | 396.75 | 17.99 | 16.8 | 17.74 | 31.08 |
Total Debt/Mcap(x) | 0.11 | 0.07 | 0.13 | 0.02 | 0.01 | 0.01 | 0.01 | 0 | 0.02 | 0.01 | 0 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 72.83 | 72.83 | 72.83 | 72.83 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 | 72.58 |
FII | 10.16 | 10.16 | 10.28 | 9.87 | 9.89 | 10.05 | 10.04 | 9.93 | 10.13 | 10.77 |
DII | 1.69 | 1.67 | 1.65 | 1.67 | 1.67 | 1.67 | 1.54 | 1.6 | 1.61 | 1.58 |
Public | 15.32 | 15.35 | 15.24 | 15.63 | 15.87 | 15.69 | 15.84 | 15.9 | 15.69 | 15.07 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 3.79 | 3.79 | 3.79 | 3.79 | 3.77 | 3.77 | 3.77 | 3.77 | 3.77 | 3.77 |
FII | 0.53 | 0.53 | 0.53 | 0.51 | 0.51 | 0.52 | 0.52 | 0.52 | 0.53 | 0.56 |
DII | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 |
Public | 0.8 | 0.8 | 0.79 | 0.81 | 0.82 | 0.82 | 0.82 | 0.83 | 0.82 | 0.78 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 | 5.2 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About